Related Experiment Video
Updated: May 17, 2026

Using Facial Electromyography to Assess Facial Muscle Reactions to Experienced and Observed Affective Touch in Humans
Published on: March 15, 2019
Empathy in electrodermal responsive and nonresponsive patients with schizophrenia
Satoru Ikezawa1, Silvia Corbera, Jiacheng Liu
1Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, United States. satoru.ikezawa@yale.edu
Schizophrenia patients show distinct skin conductance response (SCR) patterns. SCR responders exhibit heightened distress and altered brain responses, suggesting unique subgroups with different prognoses.
Area of Science:
- Neuroscience
- Psychiatry
- Psychophysiology
Background:
- Previous research indicates two schizophrenia subgroups based on skin conductance response (SCR) to emotional stimuli: absent SCR and heightened/non-habituating SCR.
- These subgroups differ in symptoms, prognosis, and social integration.
Purpose of the Study:
- To compare social cognition between schizophrenia patients with absent SCR (non-responders) and those with heightened/non-habituating SCR (responders).
- To investigate the relationship between SCR, emotional processing, and neurophysiological responses.
Main Methods:
- Measured SCR in 28 schizophrenia patients and 24 controls while viewing emotional and neutral videos.
- Assessed symptoms, neurocognition, social cognition, and social function.
- Recorded event-related potentials (ERPs), specifically P300, in response to images of people in pain versus neutral images.
Main Results:
- Schizophrenia SCR responders reported higher personal distress when viewing others in distress compared to non-responders and controls.
- Schizophrenia SCR responders showed lower P300 ERP amplitudes to others in pain than non-responders and controls.
- SCR responsiveness differentiated schizophrenia subgroups with distinct emotional and neurophysiological profiles.
Conclusions:
- Skin conductance response (SCR) can serve as a potential biomarker for identifying schizophrenia subgroups.
- These subgroups exhibit differences in underlying pathophysiology, cognitive function, and clinical outcomes.
- Understanding these subgroups is crucial for tailored treatment and prognosis in schizophrenia.
More Related Videos
Related Concept Videos
Empathy
Psychological and Sociocultural Causes of Schizophrenia
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Personality Disorders: Schizotypal and Histrionic
Schizotypal Personality Disorder: Eccentric Behavior and Social Withdrawal
Schizotypal personality disorder is marked by odd or eccentric...

